COFCO BIOTECHNOLOG financial statements, including revenue, expenses, profit, and loss

The total revenue of 000930 for the last quarter is 5.19 B CNY, and it's 0.65% higher compared to the previous quarter. The net income of Q3 24 is -51.88 M CNY.